Skip to main content
All lobbying filings

DAVITA INC.

Lobbying for DAVITA INC

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$1,000,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • ANDY VARGAS New on this filing
    Previously held: Senior Associate Director, Operations, Public Engagement & Intergovernmental Affairs - Vice President Kamala Harris (2021-2022); Staff Assistant, Legislative Correspondent, and Special Assistant - Sen. Kamala Harris (2017-2020)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 6
  • Centers For Disease Control & Prevention (CDC)
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 3
  • HR 2199
    Restore Protections for Dialysis Patients Act
  • S 1173
    Restore Protections for Dialysis Patients Act
  • HR 3944
    Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
 Lobbying activity 3
Health Issues

H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options

Medicare/Medicaid

H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options

Veterans

Issues related to Veterans Affairs and dialysis H.R. 3944, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem